Infections caused by Pseudomonas species in patients with burns and in other surgical patients.
D000287:Administration, Topical; D000818:Animals; D002056:Burns / Q000382:microbiology*; D003091:Colistin / Q000627:therapeutic use; D003428:Cross Infection / Q000209:etiology; D004195:Disease Models, Animal; D004352:Drug Resistance, Microbial; D004473:Ecthyma / Q000209:etiology; D004755:Enterobacteriaceae / Q000302:isolation & purification; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D011014:Pneumonia / Q000382:microbiology; D011532:Providencia / Q000302:isolation & purification; D011549:Pseudomonas / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification*; D011552:Pseudomonas Infections / Q000150:complications* / Q000188:drug therapy; D051381:Rats; D018805:Sepsis / Q000209:etiology / Q000517:prevention & control; D018139:Simplexvirus / Q000302:isolation & purification; D013449:Sulfonamides / Q000008:administration & dosage / Q000627:therapeutic use; D013530:Surgical Wound Infection / Q000382:microbiology*; D013924:Thrombophlebitis / Q000382:microbiology; D013997:Time Factors; D005719:gamma-Globulins / Q000627:therapeutic use
D005839:Gentamicins; D013449:Sulfonamides; D005719:gamma-Globulins; D003091:Colistin